Type 2 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 64 with a blood sugar control reading (called A1C) above 7, or people aged 65 and older with an A1C above 8, measured within the past 12 months before the study starts.
- People aged 18 to 64 with an A1C above 7, or people aged 65 and older with an A1C above 8, at the time the study begins.
- People who receive Medicaid, or both Medicaid and Medicare.
- People aged 18 or older.
- People who have been diagnosed with Type 2 diabetes.
- People who are currently using insulin as part of their diabetes treatment.
- People who have owned and regularly used an Android or iPhone smartphone for at least 6 months.
- People who are able to read and communicate in English.
- People who have adequate vision to read text messages on their own smartphone.
- People who can use their smartphone for things beyond just emailing, texting, and making phone calls (this will be assessed over the phone based on self-reported ability).
Who may not be able to join:
- People who are currently pregnant.
- People who have cognitive impairment (difficulties with memory or thinking), which will be assessed using a short screening tool called the Six-Item Screener.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Helen NC Chen, PhD, Rutgers School of Nursing
Phone: (908) 466-3953
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Glycemic control: glycated hemoglobin AIC; Glycemic control - the rate of pre-prandial blood glucose readings in target range; Glycemic control - the rate of peak postprandial blood glucose reading in target range
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.